Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nathaniel Rex"'
Autor:
Johanna M. Ospel, Nathaniel Rex, Karim Oueidat, Rosalie McDonough, Leon Rinkel, Grayson Baird, Scott Collins, Gaurav Jindal, Matthew D. Alvin, Jerrold Boxerman, Phil Barber, Mahesh Jayaraman, Wendy Smith, Amanda Amirault-Capuano, Michael D. Hill, Mayank Goyal, Ryan McTaggart
Publikováno v:
Journal of Stroke, Vol 26, Iss 2, Pp 260-268 (2024)
Background and Purpose Infarcts in acute ischemic stroke (AIS) patients may continue to grow even after reperfusion, due to mechanisms such as microvascular obstruction and reperfusion injury. We investigated whether and how much infarcts grow in AIS
Externí odkaz:
https://doaj.org/article/ac48e16445684474b2fa9024c37bb545
Autor:
Bryan Zheng, Ben Hsieh, Nathaniel Rex, Peter M. Lauro, Scott A. Collins, Andrew S. Blum, Julie L. Roth, Neishay Ayub, Wael F. Asaad
Publikováno v:
Human Brain Mapping. 43:4852-4863
Stereotactic electroencephalography (SEEG) is an increasingly utilized method for invasive monitoring in patients with medically intractable epilepsy. Yet, the lack of standardization for labeling electrodes hinders communication among clinicians. A
Publikováno v:
Neurotherapeutics.
Autor:
Michael E. Reznik, Leana Mahmoud, Daniel Kim, Bradford B Thompson, Carlin Chuck, Nathaniel Rex, Roshini Kalagara, Tracy E. Madsen, Karen L. Furie, Richard N. Jones
Publikováno v:
Neurology
Background and ObjectivesAndexanet alfa was recently approved as a reversal agent for the factor Xa inhibitors (FXais) apixaban and rivaroxaban, but its impact on long-term outcomes in FXai-associated intracerebral hemorrhage (ICH) is unknown. We aim
Autor:
Rahul A. Sastry, Konrad Walek, Owen P. Leary, Nathaniel Rex, Elias A. Shaaya, Jonathan A. Poggi, Deus Cielo
Publikováno v:
World neurosurgery. 164
Posterior fossa approaches are common neurosurgical procedures. Rates of postoperative infection, pseudomeningocele, and cerebrospinal fluid (CSF) fistula are high; however, evidence regarding predisposing risk factors and treatment outcomes remain s
Autor:
Nathaniel Rex, Leana Mahmoud, Daniel Kim, Michael E. Reznik, Roshini Kalagara, Carlin Chuck, Tracy E. Madsen, Karen L. Furie, Bradford B Thompson, Richard N. Jones
Publikováno v:
Stroke. 52
Background: Andexanet alfa was recently approved as a reversal agent for the Factor Xa inhibitors (FXai) apixaban and rivaroxaban, but its impact on long-term outcomes in FXai-associated intracerebral hemorrhage (ICH) is unknown. Methods: We performe